Jersey Shore University Medical Center Foundation

Philanthropy helps Jersey Shore University Medical Center fulfill its mission to provide the best care, close to home. Jersey Shore University Medical Center Foundation is the tax-exempt arm of the medical center and gladly accepts gifts from individuals, families, grateful patients, businesses, corporations, foundations and other similar sources. If you would like to make a gift to the medical center, but are unsure where or how you would like to lend your support, our team will gladly speak with you.

Your gift to the medical center can have a direct impact on technology, programs and services and can help us continue to provide the best care to our patients. Thank you for your support.

Tax ID Number

Jersey Shore University Medical Center Foundation: 22-2342452

The James F. Ackerman Federation

The James F. Ackerman Federation is an organization of women dedicated to helping the personnel and patients of Jersey Shore University Medical Center and K. Hovnanian Children’s Hospital. Most recently, the group committed $300,000 to support Pediatric Oncology through the Hackensack Meridian Health Tackle Kids Cancer initiative. Donations made to Tackle Kids Cancer benefit the essential clinical care, unique support services and groundbreaking cancer research needed to find a cure.

The organization raises funds through various events throughout the year such as card parties, luncheons, vendor sales, raffles, boutiques and other special events. All funds raised are used to support programs and services within the medical center.

Contact Us

Paul Huegel
Vice President of Development
Jersey Shore University Medical Center Foundation
1945 NJ-33, Neptune City, NJ 0775
Telephone: 732-751-5117
Fax: 732-751-5120

John Toomey 
Senior Development Officer
Jersey Shore University Medical Center Foundation
1945 NJ-33, Neptune City, NJ 0775
Telephone: 732-751-5161

Fundraising Priorities

Hackensack Meridian Jersey Shore University Medical Center is creating a comprehensive, multi-disciplinary Neuroscience Institute that will provide unique offerings for the communities of Monmouth, Ocean and southern Middlesex counties.

The location and setting of the Amdur Pavilion are ideal for patients with neurological diagnoses and ambulatory problems, as well as their families and caregivers. Easy access from the highway, valet parking, limited steps from the wheelchair access entrance, a large and open common waiting area, close proximity to the 3T MRI and same day surgery, infusion centers within the MS center and directly across in Hope Tower, all make this a perfect setting for Jersey Shore University Medical Center’s outpatient neuroscience subspecialties.

The outpatient setting in the Neuroscience Institute will also allow for more efficient use of the multi-disciplinary services and specialties that will be provided for many of the Neuroscience Institute’s adult and pediatric neuroscience subspecialties, including but not limited to: Pulmonology, ObGyn, Urology, Physical Therapy, Occupational Therapy, Speech Therapy, Social Work, Neuropsychology and Palliative Care.

Following is a list of comprehensive neuroscience programs that will be incorporated into the Neuroscience Institute:

  • Multiple Sclerosis Center
  • ALS (Lou Gehrig’s Disease) Center
  • Craniofacial Center
  • Epilepsy Center
  • Center for Memory and Healthy Aging (Alzheimer’s Center)
  • Center for Paralysis and Reconstructive Nerve Surgery
  • Sleep Medicine Center
  • Movement Disorder Center (Parkinson’s Disease)
  • Secondary Stroke Prevention Clinic
  • Pediatric Headache Clinic
  • Neuro-Oncology Center
  • Concussion/Sports Medicine

Jersey Shore University Medical Center is the second highest volume cardiac center in New Jersey for cardiovascular (CV) invasive procedures. In order to ensure adequate capacity to continue to grow Jersey Shore University Medical Center’s CV market leader position in the south region and leverage Hackensack Meridian Health’s presence in Middlesex County, Jersey Shore University Medical Center will require additional CV capacity.

In 2019, Jersey Shore University Medical Center physicians performed 5,626 cardiac caths, 4,187 stents and 6,509 ablations/pacemakers. In addition, they performed 747 open heart surgeries, 258 TAVRs and 24 mitral clips.

With this immense volume, Jersey Shore University Medical Center’s existing CV suite has facility challenges, is space-constrained and has issues relative to patient flow. A proposed Northwest 4 renovation and expansion plan will create state-of-the-art space for cardiovascular interventional procedures with dedicated short-stay capacity.

The current CV space includes eight procedure rooms with six needing upgrades. The proposed plan would create 10 state-of-the-art procedure rooms. All facility challenges, including room size, ceiling heights and air exchanges would be addressed for state-of-the-art catheterization and EP labs. In addition, dedicated short-stay space to prep and recover patients would be created where none exist today. High-end laser-guided robotic systems required for structural heart and other interventions would also be installed.

The Cardiovascular Invasive Procedural Expansion Project will improve the team member, physician, patient and family experience with the ability to more effectively coordinate care. It will also improve operational efficiency with enhanced CV team stability in a state-of-the-art facility.

One Oncology Program Across Two Sites

Hackensack Meridian Health’s vision for oncology:

John Theurer Cancer Center (JTCC) will be the leading cancer program in New Jersey and be recognized as one of the top programs nationally. The JTCC program will focus on delivering the best cancer care across the state.

JTCC at Hackensack University Medical Center serves as the hub of the Hackensack Meridian Health network cancer program, treating all forms of major cancer, delivering the best outcomes and doing cutting edge research.

JTCC, its satellite at Jersey Shore University Medical Center, as well as its affiliate programs across the state, will be the recognized premier brand for cancer care across the market and will continue to work with Memorial Sloan Kettering as a strategic partner in New Jersey.

Program space needs and construction:

  • Construct a new 12-bed inpatient unit on Brennen 6, Jersey Shore University Medical Center’s existing oncology floor
  • Design and build out the now vacant Hope Tower 8th floor for outpatient services
  • New oncology programs can begin prior to construction

Three areas of focus include:

  • Stem Cell Transplantation and Cellular Therapy;
  • Phase I Clinical Trials for Solid and Liquid Tumors; and a
  • Leukemia Center of Excellence.

Board of Trustees

Chairperson: John A. Giunco, Jr., Esq.

Vice Chairperson: Walter E. Earle, II

Secretary: John F. Reinhardt

Treasurer: Eric M. Kirsch, C.F.A

Chairperson (Emeritus): Peter Cancro

CEO, Hackensack Meridian Health: Robert C. Garrett

President and Chief Development Officer, Hackensack Meridian Health Foundation: Joyce P. Hendricks

President, Southern Market: Kenneth N. Sable, M.D., MBA, FACEP

President and Chief Hospital Executive, Jersey Shore University Medical Center: Vito Buccellato, MPA, LNHA

Vice President, Development: Paul Huegel


  • Nicole Agnew
  • Thomas DeFelice
  • David M. Epstein, Esq.
  • T. Burt Barham
  • Sandra Keary
  • David S. Kountz, M.D., MBA
  • Richard A. Loshiavo
  • Robert W. Mullen, Jr.
  • Kenneth D. Nahum, D.O.
  • Richard M. Neibart, M.D.
  • Harpreet Pall, M.D., MCA, CPE
  • Philip L. Perricone
  • Philip J. Scaduto
  • Robert Smith
  • Robert L. Sweeney, D.O.
  • Alexander Taylor
  • Gary Tolchin
We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy.
Accept All Cookies